Organization
First Affiliated Hospital of Gannan Medical University
3 abstracts
Abstract
SHR-1701 in combination with platinum-based chemotherapy and BP102 (a bevacizumab biosimilar) for persistent, recurrent, or metastatic cervical cancer: Data from a phase 1b/3 study.Org: Sun Yat-sen University Cancer Center Gansu Hospital, First Affiliated Hospital of Gannan Medical University, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China, The Second People's Hospital of Yibin City, Fudan University Shanghai Cancer Center,
Abstract
Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma.Org: First Affiliated Hospital of Gannan Medical University, Shanghai OrigiMed Co., Ltd., Shanghai, China,
Abstract
Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study.Org: Fudan University Shanghai Cancer Center, Guangxi Tumor Hospital, Department of Medical Oncology, Harbin Medical University Cancer Hospital, First Affiliated Hospital of Gannan Medical University, Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China,